Skip to main navigation

  • About
    • Overview
    • Management Team
    • Board of Directors
    • Partnerships
  • Product Candidates
    • Pipeline
    • tivozanib
    • ficlatuzumab
    • av-203
    • av-380
    • av-353
  • publications & presentations
  • Media
    • Press Releases
    • Media Toolkit
  • Investors
    • Overview
    • Corporate Governance
    • Stock Information
    • Research Coverage
    • SEC Filings
    • Annual Reports
    • Press Releases
    • Scientific Publications & Presentations
    • Calendar of Events
    • FAQs
    • Information Request
  • Careers
    • Life at Aveo
    • Job Openings
  • Contact

Investors

  • About
    • Overview
    • Management Team
    • Board of Directors
    • Partnerships
  • Product Candidates
    • Pipeline
    • tivozanib
    • ficlatuzumab
    • av-203
    • av-380
    • av-353
  • publications & presentations
  • Media
    • Press Releases
    • Media Toolkit
  • Investors
    • Overview
    • Corporate Governance
    • Stock Information
    • Research Coverage
    • SEC Filings
    • Annual Reports
    • Press Releases
    • Scientific Publications & Presentations
    • Calendar of Events
    • FAQs
    • Information Request
  • Careers
    • Life at Aveo
    • Job Openings
  • Contact

SEC Filing Details

SEC Filing Details

Document Details

Form
8-K
Filing Date
Aug 10, 2020
Document Date
Aug 10, 2020
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
AVEO Oncology
Issuer
AVEO PHARMACEUTICALS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT

Shareholder Tools

  • Print Page
  • RSS Feeds
  • E-mail Alerts
  • IR Contacts
© 2021 AVEO Pharmaceuticals, Inc. All rights reserved.
Terms of Use Privacy Policy
logo
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Partnerships
  • Product Candidates
    • Pipeline
    • tivozanib
    • ficlatuzumab
    • av-203
    • av-380
    • av-353
  • publications & presentations
  • Media
    • Press Releases
    • Media Toolkit
  • Investors
    • Overview
    • Corporate Governance
    • Stock Information
    • Research Coverage
    • SEC Filings
    • Annual Reports
    • Press Releases
    • Scientific Publications & Presentations
    • Calendar of Events
    • FAQs
    • Information Request
  • Careers
    • Life at Aveo
    • Job Openings
  • Contact